ClinicalTrials.gg
Status unknownNCT04623294Updated Nov 10, 2020

Online Noninvasive Assessment of Human Brain Death and Deep Coma by Near-infrared Spectroscopy

An observational study in Brain Death and Coma, sponsored by Chinese Academy of Medical Sciences. Status unknown at 1 site in China. Open to participants aged 20 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-11-10.

Sponsored by Chinese Academy of Medical Sciences · Observational

The sponsor has not verified this record recently (last verified Nov 2020), so the status shown — last known as Not yet recruiting — may be out of date.
Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
75
Ages
20 Years to 80 Years
Sex
All
01

Study summary

This study aims to assess brain death and deep coma with the self-made near infrared spectroscopy (NIRS) instrument. The investigators used the noninvasive method to monitor the Δ[HbO2] (the concentration changes in oxy-hemoglobin) and Δ[Hb] (the concentration changes in deoxy-hemoglobin) in the region around the forehead of medically evaluated participating patients and healthy subjects. A multiple-phase protocol at varied fraction of inspired O2 were utilized during the assessment.

Read the detailed description

Brain death is an irreversible loss of all brain functions, while deep coma is a profound state of unconsciousness associated with depressed cerebral activity. Timely distinguishing the two states is crucial for saving patients. The noninvasive, sensitive, universally available, and timely ancillary method to assess brain death and deep coma has not been established. This study aims to explore a noninvasive and straightforward way in brain death and deep coma online assessment. The changes of hemodynamic parameters including oxyhemoglobin (HbO2) and deoxyhemoglobin (Hb) were detected by near infrared spectroscopy instrument attached on the forehead of participators. A multiple-phase protocol at varied fraction of inspired O2(FIO2) were utilized during the assessment. Then the investigators compared the multiple physiological parameters changes among different groups at different FIO2.

02

Conditions studied

  • Brain Death
  • Coma

Browse trials for

Keywords

  • Brain death
  • Deep coma
  • Oxygen metabolism
  • Near infrared spectroscopy
03

In context

Brain Death

74 studies on the registry are indexed under Brain Death; 10 are open to participants now.

This study's planned enrollment of 75 is close to the median of 80 across 33 observational studies indexed under Brain Death.

Browse Brain Death studies →

Lead sponsor

Chinese Academy of Medical Sciences is the lead sponsor of 237 studies on the registry; 19 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Probability sample

Study population

Adult individuals of any gender. Hired from Intensive Care Center of Sichuan Provincial People's Hospital,Shanghai Xinhua Hospital and Tianjin Huanhu Hospital

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients who have had brain death or serious brain trauma.
  • Patients who have deep coma with autonomous respiration according to GCS coma Scale
  • Healthy people who are interested in optical assessment of hemodynamic parameters

Exclusion criteria

Exclusion Criteria:

  • Patients who are in pregnancy or have plan to conception.
  • Patients who have vertebra surgery or have plan of surgery.
  • Patients who are inappropriate to join this trial judged by the radiologists or specialists.
  • AIDS, Active Hepatitis, Tuberculosis, Syphilis
  • Patients who regularly take anticoagulants, antiplatelet drugs
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
75 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Brain death patients for HLH Oxygen

    Brain-dead patients were supplied with oxygen at varied FIO2 at medical premised range.The protocol is Oxygen supply of high-low-high procedure. During the procedures, the Δ\[Hb\] and Δ\[HbO2\] time courses were collected by the NIRS instrument for hemodynamic parameter.

    Procedure: Oxygen supply of high-low-high procedure

  • Brain death patients for LHL Oxygen

    Brain-dead patients were supplied with oxygen at varied FIO2 at medical premised range.The protocol is Oxygen supply of low-high-low procedure. During the procedures, the Δ\[Hb\] and Δ\[HbO2\] time courses were collected by the NIRS instrument for hemodynamic parameter.

    Procedure: Oxygen supply of low-high-low procedure

  • Deep coma patients for HLH Oxygen

    Deep coma patients were supplied with oxygen at varied FIO2 at medical premised range.The protocol is Oxygen supply of high-low-high procedure. During the procedures, the Δ\[Hb\] and Δ\[HbO2\] time courses were collected by the NIRS instrument for hemodynamic parameter.

    Procedure: Oxygen supply of high-low-high procedure

  • Deep coma patients for LHL Oxygen

    Deep coma patients were supplied with oxygen at varied FIO2 at medical premised range.The protocol is Oxygen supply of low-high-low procedure. During the procedures, the Δ\[Hb\] and Δ\[HbO2\] time courses were collected by the NIRS instrument for hemodynamic parameter.

    Procedure: Oxygen supply of low-high-low procedure

  • Healthy people for HLH Oxygen

    Healthy people were supplied with oxygen at varied FIO2 at medical premised range.The protocol is Oxygen supply of high-low-high procedure. During the procedures, the Δ\[Hb\] and Δ\[HbO2\] time courses were collected by Optical monitor for hemodynamic parameter.

    Procedure: Oxygen supply of high-low-high procedure

  • Healthy people for LHL Oxygen

    Healthy people were supplied with oxygen at varied FIO2 at medical premised range.The protocol is Oxygen supply of low-high-low procedure. During the procedures, the Δ\[Hb\] and Δ\[HbO2\] time courses were collected by Optical monitor for hemodynamic parameter.

    Procedure: Oxygen supply of low-high-low procedure

Interventions

  • ProcedureOxygen supply of high-low-high procedure

    The protocol consisted of 1-hour resting, 3-minute baseline measurement, half-hour measurement at 60% FIO2(phase I, high oxygen), half-hour measurement at 40% FIO2 (phase II, low oxygen) and half-hour measurement at 60% FIO2 (phase III, high oxygen). Device: Optical monitor for hemodynamic parameter. Near infrared spectroscopy instrument was attached on the subjects' forehead to detect the changes of hemodynamic parameters.

  • ProcedureOxygen supply of low-high-low procedure

    The protocol consisted of 1- hour resting, 3-minute baseline measurement, half-hour measurement at 40% FIO2 (phase I, low oxygen), half-hour measurement at 60% FIO2 (phase II, high oxygen) and half-hour measurement at 40% FIO2 (phase III, low oxygen). Device: Optical monitor for hemodynamic parameter. Near infrared spectroscopy instrument was attached on the subjects' forehead to detect the changes of hemodynamic parameters.

06

What researchers measure

Primary outcomes

  1. Δ[HbO2]

    The changes of oxyhemoglobin concentrations in prefrontal cortex.

    Time frame: 1 day during the whole experiment

  2. Δ[Hb]

    The changes of deoxyhemoglobin concentrations in prefrontal cortex.

    Time frame: 1 day during the whole experiment

Secondary outcomes

  1. Heart rate

    Heart rate of patient recorded by bed-side physiological monitor.

    Time frame: 1 day during the whole experiment

  2. Blood pressure

    Blood pressure of patient recorded by bed-side physiological monitor.

    Time frame: 1 day during the whole experiment

07

Study locations

1 site
  • NIRS assessment for brain death
    Tianjin, Tianjin 300000, China
08

References and documents

Publications

  • Pan B, Huang C, Fang X, Huang X, Li T. Noninvasive and sensitive optical assessment of brain death. J Biophotonics. 2019 Mar;12(3):e201800240. doi: 10.1002/jbio.201800240. Epub 2018 Dec 13. PubMed 30379409 ↗
09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Nov 2020; primary completion for Mar 2021, 4 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 9, 2020
First posted
Nov 10, 2020
StartEst.
Nov 10, 2020
Primary completionEst.
Mar 31, 2021
CompletionEst.
Dec 31, 2022
Last update
Nov 10, 2020
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Nov 10, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04623294
Responsible party
Ting Li (Full professor, Chinese Academy of Medical Sciences) — Principal investigator
First posted
Nov 10, 2020
Start date
Nov 10, 2020 (estimated)
Primary completion
Mar 31, 2021 (estimated)
Completion
Dec 31, 2022 (estimated)
Last update
Nov 10, 2020

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion